Summary.-Nineteen benign human breast tumours, from 19 premenopausal patients, were processed into slices and each tumour was individually cultured for 2 days in Medium 199. The effects of bovine insulin (5-0 ,ug/ml) human placental lactogen (10-0 jig/ml) and human growth hormone (10.0 ,ug/ml) on 3H-thymidine incorporation into DNA were determined on the cultured tumour slices. Insulin and human placental lactogen significantly (P < 0.01) increased the mean incorporation of [3H]TdR into DNA, whereas human growth hormone was ineffective. These results provide evidence that insulin and human placental lactogen, but not human growth hormone, may be important factors in the aetiology of benign human breast tumours.
IN a recent report, we provided evidence that both insulin and human placental lactogen (HPL) were mitogenic to the ductal epithelium in benign human breast tumours (Welsch and McManus, 1977) . The mitogenic activity of these peptides was assessed in vitro by measuring DNA synthesis of 2-day organ cultures of freshly biopsied benign breast dysplasias. Both peptides increased: (1) the incorporation of [3H]TdR into chemically extracted DNA, (2) the [3H]TdR autoradiographic labelling index and (3) the mitotic index of these dysplasias, suggesting that one or both of these peptides may play a role in the aetiology of this disease.
Human growth hormone (HGH) is a pituitary peptide, chemically, immunologically and physiologically similar to HPL (Forsyth, 1974; Bewley and Li, 1974; Handwerger and Sherwood, 1974) . The pituitary peptide has been reported to have lactogenic and mammary growthpromoting activities in lower animals (Forsyth, 1 974; Handwerger and Sherwood, 1974) but its effect on growth and differentiation of human breast tissues is not known. Because of the close structural similarities of HGH and HPL, it was of interest to determine whether or not HGH has mitogenic activities toward benign human breast tumours, as has been reported for HPL (Welsch and McManus, 1977 until the slices measured l 1 x 1 mm). The small slices (1 X 1 mm) were pooled and placed in 10 x 35 mm Falcon disposable Petri dishes, 10 slices/dish. Each Petri dish contained 2-0 ml of the culture medium.
Each biopsy specimen was divided into either 3 or 4 groups (i.e., a control and either 2 or 3 experimental groups). Each group (controls and experimental) had 9 small Petri dishes containing a total of 90 small slices. The small Petri dishes were placed in a covered water-saturated larger Falcon disposable Petri dish (15 x 100 mm), 3 small dishes per larger dish. The Petri dishes were then placed in a small gassing chamber and housed in an incubator at 37°C. The chambers were continuously infused with gas (95% 02-5% C02) during the culture period.
All biopsy specimens were individually cultured; slices from different specimens were never combined. The large number of randomly selected small slices per group provides reasonable assurance that an equal quantity of epithelium is distributed among the groups at the onset of culture.
The culture medium used in these studies was Medium 199, modified Earle's salts obtained from Grand Island Biological Co., Grand Island, NY. The hormones used in this study, and their concentrations in the culture media were: bovine pancreas insulin (California Biochemical Corp., La Jolla, CA, 22-5 i.u./mg) (5.0 ,g/ml); human placental lactogen (HPL, Nutritional Biochemical Corp., Cleveland, OH) (10-0 ,ug/ml); human growth hormone (HGH, NIH-HS2160E) (10.0 ,tg/ml) and HGH (California Biochemical Corp, La Jolla, CA) 10-0 Vg/ml.
All media contained gentamicin (Schering Corp., Kenilworth, NJ) (50 0 itg/ml). After all additions, the media were passed through a Millipore filter (0 45 ,um), added to the Petri dishes, and the entire culture assembly was frozen ( -20°C) until the biopsy specimens were brought to the laboratory.
At the end of the 2nd day of culture, 4 h before termination, sterile methyl-[3H]TdR (New England Nuclear, Boston, MA; 2-0 Ci/mmol) was added to the culture medium, at 1-0 ,uCi/ml. Termination of the cultures was designed to facilitate quick removal of the small slices from the media (in order to obtain a wet weight for each group) and then storage in 0-9% NaCl at -20°C until DNA extraction and analysis.
DNA extraction and analysis of cultured slices.-For DNA extraction and analysis, the tissues from each group were ground in 0-9% NaCl solution with a Willems Polytron homogenizer. An equal volume of 20% trichloracetic acid was added to the homogenate the resulting precipitate was centrifuged (3000 g) and washed twice with 10% trichloracetic acid. The precipitate was then washed twice in sodium acetate in methanol and in chloroform-methanol, once in 100% ethanol and once in 100% ethyl ether, in that order, to remove lipid and H20. In all the foregoing procedures, the preparations were kept constantly cold. The defatted-dehydrated extract was placed in a ventilated fume hood (12-18 h), then in a vacuum desiccator (24 h) and was subsequently weighed.
The defatted-dehydrated extract was digested (3 h at 37°C) with repeated stirrings in 0-3N KOH. The preparation was cooled, precipitated with cold 10% perchloric acid, centrifuged (3000 g) and washed twice. The precipitate was then incubated for 30 min with constant stirring in hot (70°C) 5% perchloric acid in which the DNA was soluible. This preparation was cooled, centrifuged (3000 g) and washed twice with cold 5% perchloric acid. The supernatant was collected for DNA and [3H]TdR analysis. DNA content was quantitatively determined (in duplicate) by the diphenylamine-colorimetric method of Burton (1956) (Welsch and McManus, 1977) . Nearly all the benign tumours were classified histologically as fibrocystic disease with varying degrees of adenosis and ductal hyperplasia. No correlation between histopathological diagnosis and response to hormones was seen.
DISCUSSION
Unlike malignant human breast tissue, normal or benign human breast tissue can be consistently and effectively maintained in short-term organ culture (Welsch et al., 1976; Welsch and McManus, 1977) . This provides a unique opportunity to study a variety of factors influential in the development, growth and differentiation of the human breast. DNA synthesis of tissue in vitro can be reliably assessed by the addition of a pulse label of [3H]TdR 4 h before termination of culture. We have previously reported (Welsch and McManus, 1977 ) that this method of quantitating DNA synthesis provides data which directly correlates with [3H]TdR labelling indices and mitotic figure analysis (i.e., when [3H]TdR incorporation into chemically extracted DNA is increased, invariably the [3H]TdR labelling index and mitotic figure index are similarly increased). Thus the procedure for assessing DNA synthesis used in this study has the advantage of being time saving yet still retains the precision for measuring mitotic activity.
Although we have previously reported that insulin and HPL are stimulatory to DNA synthesis of organ cultures of benign human breast tumours (Welsch and McManus, 1977) 
Both HPL and HGH are single-chain peptides of 190 amino-acid residues with 2 interchain disulphide bonds (Bewley and Li, 1.974) . The amino-acid compositions of the 2 hormones are very similar, the only major differences being in the number of methionine, histidine and proline residues. The 2 hormones are identical at 163 of the 190 residues, accounting for 8600 homology in the amino-acid sequences. Despite this structural similarity, the somatotrophic and lactogenic activities of these peptides in lower animals are not always parallel. In comparing the lactogenic activities of HPL and HGH, the lactogenic potency of HPL is essentially identical to HGH when measured by the pigeon-crop assay, the pseudopregnant rabbit mammary intraductal assay or the mid-pregnant mouse mammary organ culture assay (Forsyth, 1974; Handwerger and Sherwood, 1974) . The pigeon assay uses mucosa-cell proliferation as an end point, the rabbit assay uses milk production as an end point and the mouse assay uses alveolarcell proliferation and milk production as end points. In general, both peptides have slight but significant stimulatory effects in the pigeon crop assay and substantial stimulatory effects in the intraductal and organ-culture assays. Thus both peptides in lower animals appear to be not only lactogenic but mammotrophic as well. In comparing the general somatotrophic activities of the 2 peptides, it is apparent that the 2 hormones have very different growth-promoting potencies, despite their structural similarities. Li (1972) has reported that HPL has 13 % of the activity of HGH in the rodent tibia test and it is generally agreed that the general growthpromoting potency of HPL in man is minimal (McGarry and Beck, 1972) .
Despite the close chemical and physiological similarities of HPL and HGH, there appears to be a marked difference between them in their ability to stimulate DNA synthesis of benign human breast tumours. This observation is important, because it may provide insight into the structural entity of HPL prerequisite for human mammotrophic activities, a site that may not be analogous to that for lower animals for which both HPL and HGH appear to be mammotrophic.
HPL has been reported to stimulate growth of precancerous mammary-gland dysplasias in mice (Yanai and Nagasawa, 1973) . Whether or not human benign breast dysplasias are precancerous remains to be determined, although patients bearing such dysplasias are in an increased breast-cancer risk group (MacMahon and Cole, 1973) . Prolactin, a pituitary peptide structurally similar to HPL, is an important hormone in murine mammary tumorigenesis, whereas purfied growth hormone has not been definitively shown to be mammary oncogenic in lower animals (Welsch and Nagasawa, 1977) . The results presented in this study provide evidence that HPL (but not HGH) may be an important hormonal factor in the etiology of benign disease of the human breast.
